FDA Approved: ONYDA XR — Original Application (NextWave Pharmaceuticals, Inc)

View source ↗

Summary

FDA approved ONYDA XR (clonidine hydrochloride) from NextWave Pharmaceuticals as a new extended-release treatment for attention-deficit/hyperactivity disorder u…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• ONYDA XR (CLONIDINE HYDROCHLORIDE)

Snippet

ORIG AP for ONYDA XR (CLONIDINE HYDROCHLORIDE)